Viewing Study NCT05448378



Ignite Creation Date: 2024-05-06 @ 5:49 PM
Last Modification Date: 2024-10-26 @ 2:36 PM
Study NCT ID: NCT05448378
Status: COMPLETED
Last Update Posted: 2022-09-19
First Post: 2022-07-04

Brief Title: Evaluation of D-chiro-inositol Treatments
Sponsor: LoLiPharma srl
Organization: LoLiPharma srl

Study Overview

Official Title: Evaluation of the Effects of D-chiro-inositol in Female Healthy Volunteer
Status: COMPLETED
Status Verified Date: 2022-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Healthy women will take tablets containing 600 mg D-chiro-inositol twice per day for one month We will evaluate metabolic and hormonalparameters as insulienmia glycemia estradiol testosterone
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None